Associate Chief Physician in the Department of Radiology at Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, specializing in imaging diagnosis of various abdominal and pelvic diseases and breast diseases. PhD in Imaging Medicine and Nuclear Medicine, visiting scholar at the Biomedical Research Center, Department of Physics, Oakland University, Michigan, USA. With over 20 years of dedicated clinical frontline work in radiology, promoted and implemented freehand puncture localization technique under magnetic resonance imaging (MRI) guidance for suspicious breast lesions, proficient in using breast MRI dynamic contrast-enhanced and diffusion-weighted imaging techniques for the diagnosis of various breast lesions, prediction of breast cancer proliferative potential, and response to neoadjuvant chemotherapy. Currently a member of multiple multidisciplinary teams (MDT) at Renji Hospital for liver tumors, gynecological tumors, and portal hypertension, providing patients with full-cycle individualized imaging assessment covering diagnosis, treatment, follow-up, and prediction before and after treatment. Participated in multiple drug clinical trials for tumors including liver cancer, cervical cancer, and ovarian cancer, providing standardized imaging assessment for trial participants. Principal investigator of 1 National Natural Science Foundation of China project and 1 Shanghai Jiao Tong University Medical-Engineering Cross Research Fund project, and collaborating unit leader of 1 Clinical Science and Technology Innovation Project of Shanghai Shenkang Hospital Development Center. Published over 20 papers as first author or corresponding author, and co-authored 2 monographs. Awarded Renji Hospital "Advanced Individual in Teaching" in 2017, Renji Hospital "Outstanding Party Affairs Worker" in 2019, Renji Hospital "Outstanding Clinical Teaching Mentor" for standardized residency training in 2022, and honored with Renji Hospital "Benevolent Heart and Benevolent Art" Physician Award in 2023.